Fenwick & West represented Oshi Health in the transaction. Oshi Health, a virtual gastrointestinal (GI) center of excellence, announced raising $60 million in Series C funding...
Oshi Health’s $60 Million Series C Funding Round
Bezi’s $13 Million Series A Financing Round
Fenwick & West represented Bezi in the transaction. Bezi announced its $13 million Series A financing. The round was led by Benchmark, with participation from Uncork Capital...
Mozart Therapeutics’ $25 Million Series A Financing
Fenwick & West LLP represented Mozart Therapeutics on the deal. Mozart Therapeutics, a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory...
Oshi Health’s $30 Million Series B Financing
Fenwick represented Oshi Health on the deal. Oshi Health, the virtual specialty care company transforming gastrointestinal (GI) health outcomes and economics, announced its $30 million Series B...
Tebra’s $72 Million Financing
Fenwick represented Tebra on the deal. Tebra, an operating system for independent healthcare providers, announced its $72 million financing at a valuation of more than $1 billion....